Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway
Backgrounds: The circadian clock protein Rev-erbα is a crucial regulator of circadian rhythms that affects multiple molecular, cellular, and physiology pathways that control susceptibility, injury, and recovery in the neurological disorders. Emerging evidence suggest that Rev-erbα plays a key role i...
Main Authors: | Mingyue Sheng, Xun Chen, Yan Yu, Qi Wu, Junping Kou, Gangling Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1102567/full |
Similar Items
-
SR9009 improves heart function after pressure overload independent of cardiac REV-ERB
by: Hui Li, et al.
Published: (2022-07-01) -
Rev-erb agonist SR9009 inhibits the proliferation of human colon cancer cell line HCT116 through reducing autophagy
by: SHI Guang, NING Na, HOU Xiao-hong, SUN Cong, YUAN Yuan, WANG Li, WANG Xiao-hui
Published: (2020-11-01) -
Targeting Rev-Erbα to protect against ischemia-reperfusion-induced acute lung injury in rats
by: Shi-Jye Chu, et al.
Published: (2023-10-01) -
In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011
by: Lore Geldof, et al.
Published: (2016-10-01) -
REV-ERB is essential in cardiac fibroblasts homeostasis
by: Xiaokang Luo, et al.
Published: (2022-10-01)